PRGO News and Press, Perrigo Company plc From 02/27/19

Perrigo Company (PRGO) Q4 2018 Results Earnings Conference Call February 27, 2019 04:30 PM ET Company Participants Bradley Joseph - VP, Global IR Ron Winowiecki - CFO Murray Kessler - President & CEO Conference Call Participants Louise Chen - Cantor Fitzgerald Chri...

Perrigo (NASDAQ: PRGO ): Q4 Non-GAAP EPS of $0.97 misses by $0.03 ; GAAP EPS of $0.60 misses by $0.04 . More news on: Perrigo Company, Earnings news and commentary, Healthcare stocks news, Read more ...

DUBLIN , Feb. 27, 2019 /PRNewswire/ -- Full-year 2018 GAAP ("Reported") net sales of $4.7 billion , reflecting a 4% decline versus a year ago; Fourth quarter 2018 reported net sales of $1.2 billion , a 7% decline versus the prior year. Full-year 2018 Worldwide Consumer business...

Perrigo (NASDAQ: PRGO ) is scheduled to announce Q4 earnings results on Wednesday, February 27th, after market close. More news on: Perrigo Company, Earnings news and commentary, , Healthcare stocks news, Read more ...

AEGN , ALEX , AMED , ANSS , APA , ATSG , AYX , BEL , BGNE , BILI , BKNG , BOLD , BOX , CABO , CCRN , CHDN , COLL , CRC , CVNA , CWK , DAR , ECPG , ERI , ESTC , ESV , FG , FIT , FOE , FTAI , FTSI , GEF , GKOS , HGV , HHC , HPQ , ITRI , KRA , KW , LADR ,...

The Irish High Court has granted leave to Perrigo (NASDAQ: PRGO ) subsidiary Perrigo Pharma International DAC while it reviews the assessment by the Irish Office of Revenue Commissioners of €1.64B (~$1.9B) in back taxes for 2013. More news on: Perrigo Company, Healthcare stocks ...

DUBLIN , Feb. 25, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO), a leading global provider of "Quality, Affordable, Self-Care Products™" , today announced that its subsidiary, Perrigo Pharma International DAC ("Elan Pharma"), has been granted leave by the Irish High ...

BOSTON, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Block & Leviton LLP ( www.blockesq.com ), a securities litigation firm representing investors nationwide, reminds investors of the important deadlines listed below. If you have purchased or otherwise acquired any of the securities listed below...

This article is part of a series that provides an ongoing analysis of the changes made to David Einhorn’s Greenlight Capital 13F portfolio on a quarterly basis. It is based on Einhorn’s regulatory 13F Form filed on 02/14/2019. Please visit our Tracking David Einhorn's Greenlig...

BOSTON, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Block & Leviton LLP ( www.blockesq.com ), a securities litigation firm representing investors nationwide, reminds investors of the important deadlines listed below. If you have purchased or otherwise acquired any of the securities listed below...